PRMT1 and neoplasm: In addition, immunofluorescence staining for the cell proliferation marker KI-67, along with hematoxylin and eosin (HE) staining, confirmed that the loss of PRMT1 clearly inhibits tumor growth compared with the control group (Figs 6L and S7E).